Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin. [electronic resource]
Publication details: Therapeutics and clinical risk management 2017Description: 603-611 p. digitalISSN:- 1176-6336
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.